Bruce C. Cozadd
2017
Compensation breakdown
Non-Equity Incentive Plan | $961,800 |
---|---|
Option Awards | $3,669,875 |
Salary | $950,385 |
Stock Awards | $4,711,828 |
Other | $10,722 |
Total | $10,304,610 |
Cozadd received $4.7M in stock awards, accounting for 46% of the total pay in 2017.
Cozadd also received $961.8K in non-equity incentive plan, $3.7M in option awards, $950.4K in salary and $10.7K in other compensation.
Rankings
In 2017, Bruce C. Cozadd's compensation ranked 609th out of 14,666 executives tracked by ExecPay. In other words, Cozadd earned more than 95.8% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 609 | 96th |
Manufacturing | 201 | 97th |
Chemicals And Allied Products | 47 | 98th |
Drugs | 33 | 98th |
Pharmaceutical Preparations | 29 | 98th |
Cozadd's colleagues
We found five more compensation records of executives who worked with Bruce C. Cozadd at Jazz Pharmaceuticals in 2017.
2017
Suzanne Hooper
Jazz Pharmaceuticals
Executive Vice President and GC
2017
Matthew Young
Jazz Pharmaceuticals
Chief Financial Officer
2017
Russell Cox
Jazz Pharmaceuticals
Chief Operating Officer
2017
Karen Smith
Jazz Pharmaceuticals
Chief Marketing Officer
2017
Michael Miller
Jazz Pharmaceuticals
Executive Vice President U.S Commercial
News
June 10, 2022
June 11, 2021
June 12, 2020
June 14, 2019